EQS-News: Zur Rose Group successfully concluded acquisition of the e-commerce and diabetes activities of Apotal Group
Retrieved on:
Monday, August 17, 2020
The Zur Rose Group has successfully completed the acquisition of the e-commerce and diabetes activities of Apotal.
Key Points:
- The Zur Rose Group has successfully completed the acquisition of the e-commerce and diabetes activities of Apotal.
- The Swiss Zur Rose Group is Europe's largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland.
- With its business model, the Zur Rose Group offers high-quality, safe and cost-effective pharmaceutical care.
- The shares of Zur Rose Group AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker ROSE).